We are doing science for policy
The Joint Research Centre (JRC) is the European Commission's science and knowledge service which employs scientists to carry out research in order to provide independent scientific advice and support to EU policy.
In the context of the EUSEW 2018 Policy Conference, the European Commission's Joint Research Centre organises the workshop "Energy storytelling: why stories matter to scientists and policy-makers in energy policy".
Last year we released the first edition of the ‘Cultural and Creative Cities Monitor’ (https://composite-indicators.jrc.ec.europa.eu/cultural-creative-cities-monitor/), a new monitoring and benchmarking tool for 168 cities in 30 countries, aimed at promoting mutual exchange and learning with a view to raise innovative, attractive and resilient cities.
Now we are developing ‘Cultural gems’, a Mobile Web App that will:
The JRC has just launched a mobile game to help raise awareness of privacy risks and data protection rights in a fun and interactive way.
'Cyber Chronix' has a special focus on the European General Data Protection Regulation (GDPR), which comes into effect across all EU Member States on 25 May 2018.
Blockchain and other Distributed Ledger Technologies (DLTs) are immutable, encrypted and timestamped databases, in which data is recorded, validated and replicated across a decentralised network of nodes.
A range of opportunities and challenges could emerge through such technologies that will potentially enable parties who are geographically distant, or have no particular trust in each other, to record, verify and share digital or digitised assets on a peer-to-peer basis with fewer to no intermediaries.
The JRC's European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) is conducting a survey to collect scientific opinion on how to assess the relevance and fitness-for-purpose of complex in vitro models such as organ-on-chip devices to understand how to best facilitate their uptake and application in a variety of areas including biomedical research for drug development and toxicological testing for safety assessment.